Eterna Therapeutics
ERNA
#10043
Rank
$13.85 M
Marketcap
$0.27
Share price
-3.25%
Change (1 day)
-88.72%
Change (1 year)

P/S ratio for Eterna Therapeutics (ERNA)

P/S ratio as of March 2025 (TTM): 23.2

According to Eterna Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.3051. At the end of 2024 the company had a P/S ratio of 10.4.

P/S ratio history for Eterna Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202410.4-92.71%
2023143
2022N/A
2021N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.37-94.07%๐Ÿ‡บ๐Ÿ‡ธ USA
14.3-38.21%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
3.09-86.66%๐Ÿ‡ซ๐Ÿ‡ท France
8.30-64.14%๐Ÿ‡บ๐Ÿ‡ธ USA
0.2168-99.06%๐Ÿ‡ฆ๐Ÿ‡บ Australia
1.14-95.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel